References
1. Damiani G., Watad A., Bridgewood C., et al. The impact of Ramadan fasting on the reduction of PASI score, in moderate-to-severe psoriatic patients: a real-life multicenter study. Nutrients. 2019; 11 (2): E277. doi: 10.3390/nu11020277
2. Langley R.G., Krueger G.G., Griffiths C.E. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis. 2005; 64 (2): 18-23. doi: 10.1136/ard.2004.033217
3. Sawada Y., Nakamura M.J. Daily life style and psoriasis. J UOEH. 2018; 40 (1): 77-82. doi: 10.7888/juoeh.40.77
4. Takeshita J., Grewal S., Langan S.M., et al. Psoriasis and comorbid diseases: Epidemiology. J Am Acad Dermatol. 2017; 76 (3): 377-90. doi: 10.1016/j.jaad.2016.07.064
5. Nakamizo S., Honda T., Adachi A., et al. High fat diet exacerbates murine psoriatic dermatitis by increasing the number of IL- 24. 17-producing убT cells. Sci Rep. 2017; 7 (1): 14076. doi: 10.1038/ s41598-017-14292-1
6. Zuccotti E., Oliveri M., Girometta C., et al. Nutritional strategies for psoriasis: current scientific evidence in clinical trials. Eur. Rev. Med Pharmacol Sci. 2018; 22 (23): 8537-51. doi: 10.26355/eur-rev_201812_16554
7. Ahdout J.; Kotlerman J.; Elashoff D., et al. Modifiable lifestyle factors associated with metabolic syndrome in patients with pso- 26. riasis. Clin Exp Dermatol. 2012; 37: 477-83. doi: 10.1111/j.1365-2230.2012.04360.x
8. Loo C.H., Chan Y.C., Lee K.Q., et al. Clinical profile, morbidity and outcome of adult patients with psoriasis at a district hospital in Northern Malaysia. Med J Malaysia. 2015; 70 (3): 177-81.
9. Wong A.P., Kalinovsky T., Niedzwiecki A., et al. Efficacy of nutritional treatment in patients with psoriasis: a case report. Exp Ther Med. 2015; 10 (3): 1071-3. doi: 10.3892/etm.2015.2631
10. Wolters M. Diet and psoriasis: experimental data and clinical evidence. Br J Dermatol. 2005; 153: 706-14. doi: 10.1111/j.1365-2133.2005.06781.x
11. Barrea L., Nappi F., Di Somma C., et al. Environmental Risk Factors in Psoriasis: The Point of View of the Nutritionist. Int J Environ Res Public Health. 2016; 13 (5): E743. doi: 10.3390/ ijerph13070743
12. Tey H.L., Ee H.L., Tan A.S., et al. Risk factors associated with having psoriatic arthritis in patients with cutaneous psoriasis. J Dermatol. 2010; 37 (5): 426-30. doi: 10.1111/j.1346-8138.2009. 00745.x
13. Ganzetti G., Campanati A., Molinelli E., et al. Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background. World J Cardiol. 2016; 8: 120-31. doi: 10.4330/wjc.v8.i2.120
14. Gisondi P., Galvan A., Idolazzi L., et al. Management of moderate to severe psoriasis in patients with metabolic comorbidities. Front Med. 2015; 2: 1. doi: 10.3389/fmed.2015.00001
15. Fleming P., Kraft J., Gulliver W.P., et al. The relationship of obesity with the severity of psoriasis: A systematic review. J Cutan Med Surg. 2015; 19: 450-6. doi: 10.1177/1203475415586332
16. Voiculescu V.M., Lupu M., Papagheorghe L., et al. Psoriasis and metabolic syndrome - scientific evidence and therapeutic implications. J Med Life. 2014; 7: 468-71.
17. Shahwan K.T., Kimball A.B. Psoriasis and cardiovascular dis- 35. ease. Med Clin North Am. 2015; 99: 1227-42. doi: 10.1016/ j.mcna.2015.08.001
18. Upala S., Sanguankeo A. Effect of lifestyle weight loss intervention 36. on disease severity in patients with psoriasis: A systematic review and meta-analysis. Int J Obes. 2015; 39: 1197-202. doi: 10.1038/ jj o.2015.64
19. Leeds A.R. Formula food-reducing diets: a new evidence-based addition to the weight management tool box. Nutr Bull. 2014; 39: 238-46. doi: 10.1111/nbu.12098
20. Gisondi P., Del Giglio M., Di Francesco V., et al. Weight loss improves the response of obese with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized,controlled, investigator-blinded clinical trial. Am J Nutr. 2008; 88: 1242-7. doi: 10.3945/ajcn.2008.26427
21. Al-Mutairi N., Nour T. The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opin Biol Ther. 2014; 14: 749-56. doi: 10.1517/14712598.2014.900541
22. Naldi L., Conti A., Cazzaniga S., et al. Diet and physical exercise in psoriasis: a randomized controlled trial. Br J Dermatol. 2014; 170: 634-42. doi: 10.1111/bjd.12735
23. Ford A.R., Siegel M., Bagel J., et al. Dietary recommendations for adults with psoriasis or psoriatic arthritis from the medical board of the national psoriasis foundation. JAMA Dermatol. 2018; 154: 934-50. doi: 10.1001/jamadermatol.2018.1412
24. Del Giglio M., Gisondi P., Tessari G., et al. Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator-blinded study. Dermatology. 2012; 224: 31-7. doi: 10.1159/000335566
25. Jensen P., Christensen R., Zachariae C., et al. Long-term effect of weight reduction on the severity of psoriasis in a cohort derived from a randomized trial: a prospective observation al follow-up study. Am J Clin Nutr. 2016; 104: 259-65. doi: 10.3945/ajcn.115.125849
26. Di Minno M.N., Peluso R., Iervolino S., et al. Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumor necrosis factor a blockers. Ann Rheum Dis. 2014; 73: 1157-62. doi: 10.1136/annrheum-dis-2012-202812
27. Martinez-Gonzalez M.A., Garcia-Arellano A., Toledo E.A., et al. A 14-item Mediterranean diet assessment tool and obesity indexes among high-risk subjects: the PREDIMED trial. PLoS One. 2012; 7: 1-10. doi: 10.1371/journal.pone.0043134
28. Pona A., Haidari W., Kolli S.S., et al. Diet and psoriasis. Dermatol Online J. 2019; 25 (2): 13030/qt1p37435s.
29. Millsop J.W., Bhatia B.K., Debbaneh M., et al. Diet and psoriasis, part III: role of nutritional supplements. J Am Acad Dermatol. 2014; 71 (3): 561-9. doi: 10.1016/jjaad.2014.03.016
30. Barrea L., Balato N., Di Somma C., et al. Nutrition and psoriasis: Is there any association between the severity of the disease and adherence to the Mediterranean diet? J Transl Med. 2015; 13: 18. doi: 10.1186/s12967-014-0372-1
31. Festugato M. Pilot study on which foods should be avoided by patients with psoriasis. Anais Bras Dermatol. 2011; 86: 1103-8. doi: 10.1590/s0365-05962011000600006
32. Devaux S., Castela A., Archier E., et al. Topical vitamin D analogues alone or in association with topical steroids for psoriasis: a systematic review. J Eur Acad Dermatol Venereol. 2012; 26 (3): 52-60. doi: 10.1111/j.1468-3083.2012.04524.x
33. Mattozzi C, Paolino G, Salvi M., et al. Peripheral blood regulatory T cell measurements correlate with serum vitamin D level in patients with psoriasis. Eur Rev Med Pharmacol Sci. 2016; 20: 1675-9.
34. Ricceri F., Pescitelli L., Tripo L., et al. Deficiency of serum concentration of 25-hydroxyvitamin D correlates with severity of disease in chronic plaque psoriasis. J Am Acad Dermatol. 2013; 68: 511-2. doi: 10.1016/j.jaad.2012.10.051
35. Merola J.F., Han J., Li T., et al. No association between vitamin D intake and incident psoriasis among US women. Arch Dermatol Res. 2014; 306: 305-7. doi: 10.1007/s00403-013-1426-6
36. Ingram M.A., Jones M.B., Stonehouse W., et al. Oral vitamin D3 supplementation for chronic plaque psoriasis: a randomized, double-blind, placebo-controlled trial. J Dermatolog Treat. 2018; 29: 648-57. doi: 10.1080/09546634.2018.1444728
37. Gaal J., Lakos G., Szodoray P., et al. Immunological and clinical effects of alphacalcidol in patients with psoriatic arthropathy: results of an open, follow-up pilot study. Acta Derm Venereol. 2009; 89 (2): 140-4. doi: 10.2340/00015555-0555
38. Finamor D.C., Sinigaglia-Coimbra R., Neves L.C., et al. A pilot study assessing the effect of prolonged administration of high daily doses of vitamin D on the clinical course of vitiligo and psoriasis. Dermatoendocrinol. 2013; 5 (1): 222-34. doi: 10.4161/derm.24808
39. Hardikova S.A., Beloborodova E.I. The state ofthe digestive system in psoriasis. Klinicheskaya medicina [Clinical Medicine]. 2012; (2): 13-9. (in Russian)
40. Gisondi P., Del Giglio M., Cozzi A., et al. Psoriasis, the liver, and the gastrointestinal tract. Dermatol Ther. 2010; 23 (2): 155-9. doi: 10.1111/j.1529-8019.2010.01310.x
41. Smirnova S.V., Barilo A.A., Smolnikova MV. Hepatobiliary system diseases as the predictors of psoriasis progression. Vestnik Rossiis-koi akademii meditsinskikh nauk [Annals of the Russian Academy of Medical Sciences]. 2016; 2: 102-8. doi: 10.15690/vramn636 (in Russian)
42. Pietrzak D., Pietrzak A., Krasowska D., et al. Digestive system in psoriasis: an update. Arch Dermatol Res. 2017; 309 (9): 679-93. doi: 10.1007/s00403-017-1775-1777
43. Valenta R., Karaulov A., Niederberger V., et al. Molecular aspects of allergens and allergy. Adv. Immunol. 2018; 138: 195-256. doi: 10.1016/bs.ai.2018.03.002
44. Werynska-Kalemba M., Filipowska-Gronska A., Kalemba M., et al. Analysis of selected allergic reactions among psoriatic patients. J Postepy Dermatol Alergol. 2016; 33 (1): 18-22. doi: 10.5114/pdia.2014.44015
45. Guttman-Yassky E., Krueger J.G. Atopic dermatitis and psoriasis: two different immune diseases or one spectrum? Curr Opin Immunol. 2017; 48: 68-73. doi: 10.1016/j.coi.2017.08.008
46. Bonciolini V., Bianchi B., Del Bianco E., et al. Cutaneous manifestations of non-celiac gluten sensitivity: clinical histological and immunopathological features. Nutrients. 2015; 7 (9): 7798-805. doi: 10.3390/nu7095368
47. Borisova I.V., Smirnova S.V. Food allergy in children. Krasnoyarsk: Publishing House of Krasnoyarsk State Medical University; 2011: 150 p. (in Russian)
48. Skavland J., Shewry P.R., Marsh J., et al. In vitro screening for putative psoriasis-specific antigens among wheat proteins and peptides. Br J Dermatol. 2012; 166 (1): 67-73. doi: 10.1111/j.1365-2133.2011.10608.x
49. Ungprasert P., Wijarnpreecha K., Kittanamongkolchai W. Psoriasis and risk of celiac disease: a systematic review and metaanalysis. Indian J Dermatol. 2017; 62 (1): 41-6. doi: 10.4103/0019-5154.198031
50. Bhatia B.K., Millsop J.W., Debbaneh M., et al. Diet and psoriasis, part II: Celiac disease and role of a gluten-free diet. J Am Acad Dermatol. 2014; 71: 350-8. doi: 10.1016/jjaad.2014.03.017
51. Drucker A.M., Qureshi A.A., Thompson J.M., et al. Gluten intake and risk of psoriasis, psoriatic arthritis and atopic dermatitis among US women. J Am Acad Dermatol. 2019; S0190-9622 (19): 32549-56. doi: 10.1016/j.jaad.2019.08.007
52. Michadlsson G., Gerden B., Hagforsen E., et al. Psoriasis patients with antibodies to gliadin can be improved by a gluten-free diet. Br J Dermatol. 2000; 142 (1): 44-51. doi: 10.1046/j.1365-2133.2000.03240.x
53. Frikha F., Snoussi M., Bahloul Z. Osteomalacia associated with cutaneous psoriasis as the presenting feature of coeliac disease: a case report. Pan Afr Med J. 2012; 11: 58.
54. Addolorato G., Parente A., de Lorenzi G., et al. Rapid regression of psoriasis in a coeliac patient after gluten-free diet. A case report and review of the literature. Digestion. 2003; 68: 9-12. doi: 10.1159/000073220
55. Michadlsson G., Ahs S., Hammarstrom I., et al. Gluten-free diet in psoriasis patients with antibodies to gliadin results in decreased expression of tissue transglutaminase and fewer Ki67+ cells in the dermis. Acta Derm Venereol. 2003; 83: 425-9. doi: 10.1080/00015550310015022
56. Zamani F., Alizadeh S., Amiri A., et al. Psoriasis and coeliac disease; is there any relationship? Acta Derm Venereol. 2010; 90 (3): 295-6. doi: 10.2340/00015555-0829
57. Losurdo G., Principi M., Iannone A., et al. Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm. World J Gastroenterol. 2018; 24 (14): 1521-1530. doi: 10.3748/wjg. v24.i14.1521
58. Barilo A.A., Smirnova S.V. Immunological indicators of psoriatic arthritis patients in syntropy with liver pathology. Rossijskij allergologicheskij zhurnal [Russian Jornal of Allergy]. 2019; 16 (1-2): 29-32. (in Russian)